Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Biotechnology

Intellia Therapeutics

Intellia Therapeutics' headquarters in Cambridge, MA, United States

John Leonard

Yong Chang

Jessica Seitzer

Aron Stein

Marika St. Amand

Birgit Schultes

David Lebwohl

James Basta

Stephanie Williams

Kathleen Shea

Maria Natale

Edward Dulac

Eliana Clark

Jesse Goodman

Jennifer Doudna

Fred Cohen

Georgia Keresty

Muna Bhanji

Bill Chase

Brian Goff

Frank Verwiel

Nessan Bermingham

Luciano Marraffini

Andy May

Derrick Rossi

Erik Sontheimer

The Research and Development team at Intellia Therapeutics is dedicated to advancing innovative genome editing therapies aimed at treating severe and life-threatening diseases. This multidisciplinary group conducts cutting-edge research, manages clinical trials, and collaborates on product planning and regulatory strategies to ensure the safe and effective development of new gene editing treatments. Their expertise spans pharmacovigilance, biostatistics, assay development, and supply chain management, driving the progression of therapies from concept to clinical application.

Research and Development

The Leadership Team at Intellia Therapeutics is responsible for setting the strategic direction and operational execution of the company's mission to develop innovative gene editing treatments. Comprising executives from key functional areas such as R&D, regulatory affairs, human resources, and financial planning, this team collaborates to drive organizational growth, ensure effective communication with stakeholders, and oversee compliance with industry regulations to transform the lives of patients with severe diseases.

Leadership Team

The Corporate Governance and Legal team at Intellia Therapeutics is responsible for overseeing legal compliance and corporate governance matters, ensuring that the company adheres to industry regulations and best practices. This team provides strategic legal support for corporate transactions, intellectual property management, and board governance, playing a crucial role in safeguarding the company’s interests while facilitating its mission to develop innovative gene editing therapies.

Corporate Governance and Legal

This department oversees the execution and administration of clinical operations, data management, and regulatory affairs to ensure compliance and efficiency in clinical programs.

Clinical Operations and Management

This department is responsible for ensuring that products and services meet defined quality standards and compliance regulations.

Quality Assurance

The Scientific and Technical Positions team at Intellia Therapeutics is dedicated to advancing genome editing technologies through a multidisciplinary approach. This team, comprising engineers, scientists, and computational experts, collaboratively designs, develops, and optimizes processes and tools essential for the discovery and manufacture of innovative gene therapies. Their work is pivotal in transforming scientific research into viable treatment options for severe diseases.

Scientific and Technical Positions

Intellia Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Corporate Governance and Legal

Clinical Operations and Management

Quality Assurance

Scientific and Technical Positions

Offices

Intellia Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Corporate Governance and Legal

Clinical Operations and Management

Quality Assurance

Scientific and Technical Positions

Offices

Related companies